Search

Search Constraints

You searched for: Author/Creator Figg, W.D.

Search Results

4. Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750—an antisense oligonucleotide against eIF4E—in combination with irinotecan in solid tumors and irinotecan‐refractory colorectal cancer. Issue 7 (27th June 2016)